Extendicare Inc. (TSE:EXE) Given Consensus Rating of “Hold” by Brokerages

Extendicare Inc. (TSE:EXE) has earned a consensus rating of “Hold” from the eight ratings firms that are presently covering the firm, MarketBeat.com reports. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is C$8.38.

$0.08 EPS Expected for BRP Group, Inc. (NASDAQ:BRP) This Quarter

Equities research analysts expect BRP Group, Inc. (NASDAQ:BRP) to post earnings of $0.08 per share for the current quarter, Zacks reports. Five analysts have made estimates for BRP Group’s earnings, with the highest EPS estimate coming in at $0.11 and the lowest estimate coming in at $0.07. BRP Group reported earnings of $0.06 per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 33.3%. The business is expected to announce its next earnings results on Thursday, March 10th.

Short Interest in Thryv Holdings, Inc. (NASDAQ:THRY) Grows By 19.4%

Thryv Holdings, Inc. (NASDAQ:THRY) saw a large increase in short interest during the month of December. As of December 15th, there was short interest totalling 1,660,000 shares, an increase of 19.4% from the November 30th total of 1,390,000 shares. Based on an average daily volume of 374,900 shares, the days-to-cover ratio is currently 4.4 days. Currently, 5.7% of the shares of the stock are sold short.

Saia, Inc. (NASDAQ:SAIA) Short Interest Update

Saia, Inc. (NASDAQ:SAIA) was the target of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 1,010,000 shares, a growth of 19.4% from the November 30th total of 845,700 shares. Based on an average daily volume of 247,700 shares, the short-interest ratio is currently 4.1 days. Currently, 3.8% of the shares of the company are sold short.

UiPath (NASDAQ:PATH) Raised to Overweight at Wells Fargo & Company

UiPath (NASDAQ:PATH) was upgraded by analysts at Wells Fargo & Company from an “equal weight” rating to an “overweight” rating in a research note issued to investors on Thursday, Analyst Ratings Network reports. The firm presently has a $60.00 target price on the healthcare company’s stock. Wells Fargo & Company’s price objective would suggest a potential upside of 51.48% from the stock’s previous close.

error: Content is protected !!